BNGO News and Press, Bionano Genomics Inc. From 10/12/21

Designed to accelerate the adoption of optical genome mapping (OGM) with the integration of BioDiscovery’s N x Clinical software solution for variant analysis Adds a world-class team, software and bioinformatics capabilities to address a broad range of application...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Bionano Genomics (NASDAQ: BNGO ) has turned into a bear of a meme play. But is there a chance for bullish DNA to be reproduced in BNGO stock? Source: Natali_ Mis/ShutterStock.com Let’s check in with ...

SAN DIEGO, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), developer of the Saphyr ® system that uses optical genome mapping (OGM) for the detection and analysis of structural variants (SVs), today announced that the following individuals have joined the Company&#x...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Today,  Bionano Genomics  (NASDAQ: BNGO ) is among the big movers in the market. Currently, shares of BNGO stock are up nearly 6% as investors pile into this genomics play. Source: Natali_ Mis/ShutterS...

SAN DIEGO, Sept. 29, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO) today announced the publication of the largest clinical research study to date evaluating optical genome mapping (OGM) for facioscapulohumeral muscular dystrophy (FSHD), which concluded that OGM can be performed mor...

Accommodative trends in the gene therapy and diagnostic market seem to serve as long-term, slow-growth tailwinds instead of a firm revenue bump catalysts. Advancement in throughput, efficiency, and costs offset higher demand from a slowly growing industry, dampening the market for new...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Investors have been rather wary about rapidly growing tech stocks that have not yet fully proven themselves since Q1 numbers started coming out in March. In some cases, the resulting haircuts that such names took have defin...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Life sciences company Bionano Genomics  (NASDAQ: BNGO ) stands apart from the competition as an innovator in optical genome mapping. Yet, BNGO stock has been stuck in a range and seems to be going nowhere. Sou...

SAN DIEGO, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced a study finding the combination of optical genome mapping (OGM) and short-read next-generation sequencing (NGS) provides a comprehensive genome analysis for lung cancer samples and enables th...

SAN DIEGO and SHANGHAI, China, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that NuProbe Global, a global molecular diagnostics company based in Shanghai, China and Houston, Texas, has adopted Bionano’s Saphyr system for optical genome mapp...